SCHEMBL3803261

SCHEMBL3803261

C=CC(OP(OC(C=C)c1ccccc1)OC(C=C)c1ccccc1)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.33
▸ MAPT P10636 4/20 0.33
▸ CYP3A4 P08684 4/20 0.33
▸ ALOX15 P16050 3/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HPGD P15428 3/20 0.33
▸ TDP1 Q9NUW8 3/20 0.33
▸ USP2 O75604 2/20 0.33
▸ TP53 P04637 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TSHR P16473 2/20 0.32
▸ DPP4 P27487 2/20 0.32
▸ F2 P00734 1/20 0.32
▸ CASR P41180 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5888648 0.85 KDM4E (0.34) KDM4EMAPTCYP3A4ALOX15HPGD
SCHEMBL3803263 0.83 CYP2C19 (0.35) KDM4EMAPTCYP3A4ALOX15CYP2C19
SCHEMBL2488648 0.79 CYP2C19 (0.36) KDM4EMAPTCYP3A4ALOX15CYP2C19
SCHEMBL3802806 0.79 CYP2C19 (0.36) KDM4EMAPTCYP3A4ALOX15CYP2C19
SCHEMBL252297 0.79 CYP3A4 (0.37) KDM4EMAPTCYP3A4ALOX15CYP2C19
SCHEMBL2950286 0.77 CYP2C19 (0.35) KDM4EMAPTCYP3A4ALOX15CYP2C19
SCHEMBL194133 0.76 KDM4E (0.40) KDM4EMAPTCYP3A4ALOX15CYP2C19
SCHEMBL17616783 0.76 CYP2C19 (0.34) KDM4EMAPTCYP3A4ALOX15CYP2C19
SCHEMBL2463795 0.76 CYP2C19 (0.38) KDM4EMAPTCYP3A4ALOX15CYP2C19
SCHEMBL3291158 0.76 SLC6A4 (0.39) KDM4EMAPTCYP3A4ALOX15CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114773747-A Application of dihydropyridine polymer in preparation of PVC (polyvinyl chloride) material 兰州金睿合新材料科技有限责任公司 2022-07-22 — — CN claimed
EP-0025544-B1 THERMOPLASTIC COMPOSITION HOECHST AKTIENGESELLSCHAFT (DE) 1983-07-27 — — EP claimed
US-4280940-A TRANSPARENT COMPOSITIONS OF GOOD VISCOSITY AND RESISTANCE TO LIGHT AND WEATHER HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-28 — — US claimed
CN-114773747-A Application of dihydropyridine polymer in preparation of PVC (polyvinyl chloride) material 兰州金睿合新材料科技有限责任公司 2022-07-22 — — CN disclosed
US-20150210828-A1 STERICALLY HINDERED AMINES BASF SE (DE) 2015-07-30 — — US disclosed
US-7683202-B2 Permanent surface modifiers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-03-23 — — US disclosed
US-20080249252-A1 New permanent surface modifiers PICCINELLI PIERO 2008-10-09 — — US disclosed
US-20050197433-A1 Molecular weight modification of thermoplastic polymers CIBA SPECIALTY CHEMICALS CORP. 2005-09-08 — — US disclosed
EP-0982356-A2 Improved stabilized coatings Clariant Finance (BVI) Limited (VG) 2000-03-01 — — EP disclosed
US-5684070-A FILM WITH TRIAZINE RESORCINOL COMPOUND STABILIZERS FOR RADIATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION (US) 1997-11-04 — — US disclosed
US-4280940-A TRANSPARENT COMPOSITIONS OF GOOD VISCOSITY AND RESISTANCE TO LIGHT AND WEATHER HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249252-A1 New permanent surface modifiers SGMS1, SGMS2, PLIN5 KDM4E 686/4885MAPT 1142/4885CYP3A4 2062/4885
US-20150210828-A1 STERICALLY HINDERED AMINES CCNA1, C5, H1-0 KDM4E 2063/4885MAPT 1834/4885CYP3A4 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback